Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Paying $37.5M for Varian's ICP-MS, Lab GC, GC-QQQ-MS Businesses


This story originally ran on March 15.

Bruker is paying $37.5 million for three Varian businesses as part of that company’s acquisition by Agilent Technologies, Bruker disclosed in a document filed with the US Securities and Exchange Commission last week.

As part of Agilent’s $1.5 billion acquisition of Varian, the two firms were required by the European Commission to divest a number of businesses [See PM 01/22/10].

Last week, Bruker and Agilent announced that Bruker would be purchasing certain Varian product lines including its inductively coupled plasma mass spectrometers, laboratory GC instruments, and GC triple-quadrupole mass specs. The firms also said that they intend to enter into a transitional services agreement and a supply agreement to continue the uninterrupted delivery of products and services to current and new customers of the three businesses.

The sale to Bruker of the businesses is expected to close by April 30. In its SEC document, Bruker further added that if the deal does not close by July 25 —extendible to Aug. 24 under certain conditions — either party can terminate the transaction without penalty.

Bruker also said that it will offer employment to “the majority” of employees of the three businesses.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.